Fundraising Fox

Revalia Bio, Inc.

New Haven, US · Founded 2021 · Delaware corporation · 6 known investors

revaliabio.com ↗

Revalia uses AI to transform donated human organs and tissues into biological datasets and clinical insights for drug and device development. The company provides end-to-end infrastructure for generating, integrating, and delivering human biology data at scale to accelerate medical research and reduce reliance on approximate biological models.

AI & Machine LearningBiotechDeep Techin /revaliabio@RevaliaBio

Founders & leadership

GTGreg Tietjen
Greg TietjenCo-Founder & Chief Executive Officer
JDJenna DiRito
Jenna DiRitoCo-Founder
KSKourosh Saeb-Parsy
Kourosh Saeb-ParsyCo-Founder
MA
Milad AlucozaiDirector
BW
Brian WilcoveDirector

Investors · 6

America's Frontier FundArlington · $500K – $10M
Connecticut InnovationsNew Haven · $500K – $2M
DniproPalo Alto
Sierra VenturesSan Mateo · $10M
BoxOne VenturesreportedMontréal · $500K
Entrepreneur FirstreportedBengaluru · $1M – $7Mvia Milad Alucozai · board

Reported raises · per SEC filings

Form D private placements
▶$12.3MraisedNov 2024 · 32 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Milad AlucozaiDirector
  • Brian WilcoveDirector
  • Gregory T. TietjenExecutive Officer, Director
Offering amount
$17M
Amount sold
$12.3M
First sale
Oct 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news